Marshall Wace’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$312K Sell
142,008
-100,368
-41% -$221K ﹤0.01% 2178
2025
Q1
$281K Buy
+242,376
New +$281K ﹤0.01% 2171
2024
Q4
Sell
-63,759
Closed -$217K 2487
2024
Q3
$217K Sell
63,759
-385,394
-86% -$1.31M ﹤0.01% 2107
2024
Q2
$2.1M Sell
449,153
-342,167
-43% -$1.6M ﹤0.01% 1231
2024
Q1
$5.87M Sell
791,320
-319,882
-29% -$2.37M 0.01% 830
2023
Q4
$11.3M Sell
1,111,202
-1,083,604
-49% -$11M 0.02% 556
2023
Q3
$17.1M Sell
2,194,806
-643,511
-23% -$5.02M 0.03% 446
2023
Q2
$23.4M Buy
+2,838,317
New +$23.4M 0.05% 379
2023
Q1
Sell
-23,867
Closed -$212K 2253
2022
Q4
$212K Buy
+23,867
New +$212K ﹤0.01% 2097
2022
Q2
Sell
-17,725
Closed -$337K 2800
2022
Q1
$337K Sell
17,725
-368,902
-95% -$7.01M ﹤0.01% 2238
2021
Q4
$10.3M Buy
+386,627
New +$10.3M 0.02% 780
2019
Q1
Sell
-17,905
Closed -$408K 1788
2018
Q4
$408K Buy
+17,905
New +$408K ﹤0.01% 1162